Literature DB >> 2841761

Concerted nonsyntenic allelic loss in human colorectal carcinoma.

D J Law1, S Olschwang, J P Monpezat, D Lefrançois, D Jagelman, N J Petrelli, G Thomas, A P Feinberg.   

Abstract

Familial polyposis coli (FPC) is caused by an autosomal dominant gene on chromosome 5, and it has been proposed that colorectal cancer in the general population arises from loss or inactivation of the FPC gene, analogous to recessive tumor genes in retinoblastoma and Wilms' tumor. Since allelic loss can be erroneously scored in nonhomogeneous samples, tumor cell populations were first microdissected from 24 colorectal carcinomas, an additional nine cancers were engrafted in nude mice, and nuclei were flow-sorted from an additional two. Of 31 cancers informative for chromosome 5 markers, only 6 (19%) showed loss of heterozygosity of chromosome 5 alleles, compared to 19 of 34 (56%) on chromosome 17, and 17 of 33 (52%) on chromosome 18. Therefore, it appears that (i) FPC is a true dominant for adenomatosis but not a common recessive gene for colon cancer; and (ii) simple Mendelian models involving loss of alleles at a single locus may be inappropriate for understanding common human solid tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841761     DOI: 10.1126/science.2841761

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  27 in total

1.  Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.

Authors:  S Rowley; K M Newbold; J Gearty; M R Keighley; I A Donovan; J P Neoptolemos
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

2.  Alternative genetic pathways in colorectal carcinogenesis.

Authors:  S Olschwang; R Hamelin; P Laurent-Puig; B Thuille; Y De Rycke; Y J Li; F Muzeau; J Girodet; R J Salmon; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Colonic aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity.

Authors:  T P Pretlow; M A O'Riordan; M F Kolman; J A Jurcisek
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

Review 4.  Recombinant DNA and surgery.

Authors:  J M Brown; A H Harken; J B Sharefkin
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

5.  Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis.

Authors:  C A Cartwright; A I Meisler; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

6.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

7.  Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas.

Authors:  M el-Azouzi; R Y Chung; G E Farmer; R L Martuza; P M Black; G A Rouleau; C Hettlich; E T Hedley-Whyte; N T Zervas; K Panagopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer.

Authors:  L H Augenlicht; J Taylor; L Anderson; M Lipkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Allelic imbalance and microsatellite instability of the DCC gene in colorectal cancer in patients under the age of 35 using fluorescent DNA technology.

Authors:  R Chetty; R Naidoo; J Schneider
Journal:  Mol Pathol       Date:  1998-02

10.  Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.

Authors:  Kyung A Kwon; Sung Hyun Kim; Sung Yong Oh; Suee Lee; Jin-Yeong Han; Kyeong Hee Kim; Ri Young Goh; Hong Jo Choi; Ki Jae Park; Mee Sook Roh; Hyo-Jin Kim; Hyuk-Chan Kwon; Jong Hoon Lee
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.